|
17/11/2021
|
Company update: "Focusing on core hospital operations" – Neutral (TP Bt3.8)
|
|
15/11/2021
|
Earnings brief: "3Q21: Record high, beat estimates" – Neutral (TP Bt3.8)
|
|
02/11/2021
|
Company update: "Expect record high in 3Q21F" – Neutral (TP Bt3.8)
|
|
13/08/2021
|
Earnings brief: "2Q21: Record high, beat estimates" – Downgrade to
Neutral (TP Bt3.8)
|
|
21/05/2021
|
Company update: "Looking at healthy earnings in 2Q21F" – Outperform (TP Bt3.3)
|
|
17/05/2021
|
Earnings brief: "1Q21: Beat estimates on better margin" – Outperform (TP Bt3.3)
|
|
08/03/2021
|
Company update: "Strong earnings to continue in 2021" – Outperform (TP Bt3.3)
|
|
01/03/2021
|
Earnings brief: "4Q20: Beat estimates" – Outperform (TP Bt3.3)
|
|
30/12/2020
|
Company update: "Like CHG as an earnings conviction play" – Outperform (TP Bt2.90)
|
|
16/11/2020
|
Earnings brief: "3Q20: Beat estimates" – Outperform (TP Bt2.90)
|
|
03/09/2020
|
Company update: "Healthy earnings to continue" – Outperform (TP Bt2.90)
|
|
17/08/2020
|
Earnings brief: "2Q20: Beat estimates on good EBITDA margin" - Buy (TP Bt2.80)
|
|
22/05/2020
|
Company update: "Patients coming back" – Buy (TP Bt2.80)
|
|
18/05/2020
|
Earnings brief:
"1Q20: Results in line with expectations" –
Buy (TP Bt2.80)
|
|
23/04/2020
|
Company update: "Sheltered from COVID-19 in 1Q20" - Buy (TP Bt2.80)
|
|
06/03/2020
|
Company update: "Sheltered from fallout from COVID-19" - Buy (TP Bt2.80)
|
|
02/03/2020
|
Earnings Brief: "4Q19: Missed on weak EBITDA margin" - Buy (TP Bt2.80)
|
| |
|
| |
|
FOLLOW US
SCB's Facbook INVX's Twitter